ArticleJournal of oncology2018

Additional Biomarkers beyond RAS That Impact the Efficacy of Cetuximab plus Chemotherapy in mCRC: A Retrospective Biomarker Analysis.

Peng Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.